joshmitchellmd's profile picture. Cardiologist at Washington University in St. Louis. #CardioOnc, evidence-based medicine, prevention, patient advocacy. Army veteran (#RLTW). Opinions my own.

Joshua Mitchell

@joshmitchellmd

Cardiologist at Washington University in St. Louis. #CardioOnc, evidence-based medicine, prevention, patient advocacy. Army veteran (#RLTW). Opinions my own.

Joshua Mitchell reposted

Check out our publication in #CardioOncology. Atrial fibrillation/flutter in stem cell transplant patients. Prevalence, association with outcomes, and impact on healthcare resource-utilization/readmissions. @joshmitchellmd @Teebi_MD rdcu.be/euXbx


Joshua Mitchell reposted

3 years ago my good friend @MorenoMDPhD approached me about this crazy idea to fill a much needed gap in heart failure education (1/3).

BKopeckyMDPhD's tweet image. 3 years ago my good friend @MorenoMDPhD approached me about this crazy idea to fill a much needed gap in heart failure education (1/3).

Congrats to Matt Lui, outstanding @WashUCardiology fellow, on his study showing that a visual review of CAC on NSCLC RAD planning CT was more predictive of CV events than Rad dose. Visual review ~ formal CAC score. #cardioonc @ICOSociety @SBRT_CR link.springer.com/10.1186/s40959…


Congrats to @RajaZaghlol for leading our contemporary review of CV complications from radiation therapy including historic trends and current recs. Always great to work with @carmenbergom @DrLPedersen and @yoo_sgkyle! #cardioonc @WashUCardiology authors.elsevier.com/a/1jze-2ct9A1t…

joshmitchellmd's tweet image. Congrats to @RajaZaghlol for leading our contemporary review of CV complications from radiation therapy including historic trends and current recs. Always great to work with @carmenbergom @DrLPedersen and @yoo_sgkyle! #cardioonc @WashUCardiology 

authors.elsevier.com/a/1jze-2ct9A1t…

Congrats to @gwalls89 for an excellent manuscript detailing the practice patterns and general uptake of guidelines in #radonc internationally. Interesting insights! #cardioonc @icosociety @gerryhanna doi.org/10.1016/j.clon…

joshmitchellmd's tweet image. Congrats to @gwalls89 for an excellent manuscript detailing the practice patterns and general uptake of guidelines in #radonc internationally.  Interesting insights!  #cardioonc @icosociety @gerryhanna

doi.org/10.1016/j.clon…

Awesome work by @RajaZaghlol exploring the CV effects of CAR-T in the Medicare population. Well-deserved! Special thanks to @kejoynt, @dgermain21 and Elena Deych, among others as well! Looking forward to the manuscript! @WashUCardiology #cardioonc

Proud to be selected as a YIA finalist in the #GCOS2024 presenting our work investigating MACE in older adults receiving CART therapy. Special thanks to @joshmitchellmd for exceptional mentoring. @ICOSociety

RajaZaghlol's tweet image. Proud to be selected as a YIA finalist in the #GCOS2024 presenting our work investigating MACE in older adults receiving CART therapy. Special thanks to @joshmitchellmd  for exceptional mentoring. @ICOSociety


Excellent symposium on #cardionc with a nice balance of presentations on the breadth of the field. Congrats to @JLiu_MSKCardOnc and @DrGuptaD and the rest of the planning committee. #mskcardionccme @MSKCancerCenter @WashUCardiology

Masterful review of radiation heart disease and optimal strategies for surveillance by @joshmitchellmd #MSKCardioOncCME @MSKCME @genomics212

DrSFeldman's tweet image. Masterful review of radiation heart disease and optimal strategies for surveillance by @joshmitchellmd  #MSKCardioOncCME @MSKCME @genomics212


Look forward to seeing everyone on Saturday for a packed agenda on #amyloidosis! Great speakers from @WUSTLmed and @PennMedicine as well as our esteemed grad @CampbellMDPhD! Free registration for trainees and patients/families. @Amyloidosisfdn @CyclingDoctor @WashUCardiology

The Continuing Medical Education - Amyloidosis 2024: Update on Best Practices for Early Detection and Treatment - will be Saturday, April 27th. It's designed for healthcare providers involved in the diagnosis or management of amyloidosis. @WUSTLmed Info> l8r.it/AWoN

WashUDeptMed's tweet image. The Continuing Medical Education - Amyloidosis 2024: Update on Best Practices for Early Detection and Treatment - will be Saturday, April 27th. It's designed for healthcare providers involved in the diagnosis or management of amyloidosis. @WUSTLmed

Info> l8r.it/AWoN


Great partnering with @myocardialsoln + the team on this important study. MRI myocardial strain is the most sensitive way to detect early cardiotoxicity. Excited to determine how early detection can best guide cardioprotection to improve heart health. @WashUCardiology #cardioonc

joshmitchellmd's tweet image. Great partnering with @myocardialsoln + the team on this important study. MRI myocardial strain is the most sensitive way to detect early cardiotoxicity. Excited to determine how early detection can best guide cardioprotection to improve heart health. @WashUCardiology #cardioonc

Joshua Mitchell reposted

Register now for @WUSTLmed @WUDeptMedicine Amyloidosis 2024 Symposium on April 27th- free for trainees! For details and to register, visit cme.wustl.edu/index.cfm?do=p…

WashUCardiology's tweet image. Register now for @WUSTLmed @WUDeptMedicine   Amyloidosis 2024 Symposium on April 27th- free for trainees! For details and to register, visit cme.wustl.edu/index.cfm?do=p…

Joshua Mitchell reposted

Excited to share this preprint. Serial, routine troponin-I screening in 428 consecutive patients treated with immunotherapy at our center was correlated with lower rates of grade 4-5 cardiovascular adverse events without a change in oncologic time on tx medrxiv.org/content/10.110…


Joshua Mitchell reposted

Published in @Heart_BMJ --"Moving towards establishing centres of excellence in cardiac amyloidosis: an International Cardio-Oncology Society @ICOSociety statement"--an important step in improving care for our patients with #amyloidosis. #CardioOnc @joshmitchellmd @WashUOnc

CyclingDoctor's tweet image. Published in @Heart_BMJ --"Moving towards establishing centres of excellence in cardiac amyloidosis: an International Cardio-Oncology Society @ICOSociety  statement"--an important step in improving care for our patients with #amyloidosis.
#CardioOnc @joshmitchellmd @WashUOnc…

Joshua Mitchell reposted

New Podcast from @JACCJournals Cardio-OncologyPulse featuring Dr. Joshua Mitchell, @joshmitchellmd highlighting education! @WUCardioFellows jacc.org/cardio-oncolog…


Joshua Mitchell reposted

Is apical sparing on echo sufficient for the diagnosis of cardiac amyloidosis? In this multicenter study, we identified 544 patients with CA and 200 controls (suspicion for CA but ruled out for CA), as well as 174 healthy subjects. Led by @JSlivnickMD academic.oup.com/ehjcimaging/ad…

Richardkcheng2's tweet image. Is apical sparing on echo sufficient for the diagnosis of cardiac amyloidosis?  In this multicenter study, we identified 544 patients with CA and 200 controls (suspicion for CA but ruled out for CA), as well as 174 healthy subjects. Led by @JSlivnickMD academic.oup.com/ehjcimaging/ad…

Unfortunately, the initial published graphic was hard to interpret. The updated graphic (same link) now more clearly shows the significant difference in CV events across cancer types. Take a look!

It's incredible to visualize the prevalence of CV risk factors across cancers, and the high rate of CV events in lung cancer especially. Work to do! Congrats to the team! @wustlmed @WashUCardiology #cardioonc @icos Dan Lenihan @ScienceAtBMS esmoopen.com/article/S2059-…



Joshua Mitchell reposted

1/ Check out our recent publication in @JCardFail ! The Cardiac Amyloidosis Registry Study (CARS): Rationale, Design and Methodology - onlinejcf.com/article/S1071-…

LilySternMD's tweet image. 1/ Check out our recent publication in @JCardFail !

The Cardiac Amyloidosis Registry Study (CARS): Rationale, Design and Methodology - onlinejcf.com/article/S1071-…

It's incredible to visualize the prevalence of CV risk factors across cancers, and the high rate of CV events in lung cancer especially. Work to do! Congrats to the team! @wustlmed @WashUCardiology #cardioonc @icos Dan Lenihan @ScienceAtBMS esmoopen.com/article/S2059-…


Loading...

Something went wrong.


Something went wrong.